Rural Obstetrics Readiness Act

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; Inclusion of pregnant and lactating individuals in research (general); Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of ob-gyn units in rural hospitals on patient access to care and maternal morbidity and mortality; I H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; Telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; S. 712/H.R. 8532, Connected MOM Act; S. 4079/H.R. 8383, Rural Obstetrics Readiness Act; Diversity, Equity, and Inclusion in medicine (general); S. 5236, Keeping Obstetrics Local Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); H.R. 8037/S. 4147, NIH IMPROVE Act; S. 2840, Bipartisan Primary Care and Health Workforce Act; S. 1840/H.R. 3916, SCREENS for Cancer Act; H.R. 10280, Strengthening Pathways to Health Professions Act; S. 5428/S. 10297, Jeanette Acosta Invest in Womens Health Act; S. 3247/H.R. 6298 Stop Shackling and Detaining Pregnant Women Act; H.R. 3503, NIH Clinical Trial Diversity Act; S. 3211/H.R. 6025, Healthcare Workforce Resilience Act; H.R. 3633, PREVENT HPV Cancers Act; S. 1409/H.R. 7891, Kids Online Safety Act; Patient-physician relationship (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); Reproductive health data privacy (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Coverage for infertility (general); Protections for in vitro fertilization (general); HPV vaccination (general); RSV vaccination (general); NIH restructuring (general); NICHD Strategic Plan (general); physician liability (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general);; human milk in NICUs; Executive Order 13952; EMTALA implementation (general); Medicare conditions of participation regarding opioids; Paid leave for patients who experience a stillbirth; menthol cigarettes and flavored cigars; nicotine limits in cigarettes; National Strategic Plans for HIV/AIDS, STIs, Vaccines and Viral Hepatitus; environmental health curriculum in medical school; heat-related deaths; hypertension in pregnancy and postpartum; adolescent reproductive health; immediate postpartum LARC; no-cost contraceptive coverage; access to fertility services and treatments; improving postpartum health care visit rates; worksite lactation support programs; newborn nutrition; Levels of Maternal Care; newborn screening; contraceptive and fertility counseling for patients with cancer; access to PrEP; maternal vaccinations; HPV vaccinations; syphilis screening during pregnancy; oral health care during pregnancy; opioid use disorder treatment for pregnant and postpartum individuals.

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Abortion access (general); Access to mifepristone (general); Contraception (general); IUD insertion (general); Maternal mortality and morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; Inclusion of pregnant and lactating individuals in research (general); Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of ob-gyn units in rural hospitals on patient access to care and maternal morbidity and mortality; Impact of abortion restrictions on patient outcomes and the ob-gyn workforce (general); H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 3310/S. 2239, Kira Johnson Act; H.R. 3312/S. 1602, Moms Matter Act; H.R. 3320/S. 1599, Data to Save Moms Act; H.R. 3523/S. 1710, Perinatal Workforce Act;; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; Telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; implementation of P.L. 118-69, Maternal and Child Health Stillbirth Prevention Act; Stillbirth prevention (general); S.___, Supporting Healthy Moms and Babies Act; S. 712/H.R. 8532, Connected MOM Act; S. 4079/H.R. 8383, Rural Obstetrics Readiness Act; Diversity, Equity, and Inclusion in medicine (general); S. 5236, Keep Obstetrics Local Act; H.R. 7855, H.R.___, Diane Powis Ovarian Cancer Testing Access Act;; S. 4445, Right to IVF Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); ; H.R. 8796/S. 4619, Stop Comstock Act; H.R. 8037/S. 4147, NIH Improve Act; H.R. 9886, Broadening Utilization of Proven and Effective Treatment for Recovery Act or the BUPE for Recovery Act; S. 4522, Dads Matter Act; H.R. 6716/S. 3509, Healthy MOM Act; H.R. 8839, Maternal and Infant Syphilis Prevention Act; H.R. 8223/S. 4246 Advancing Menopause Care and Mid-Life Womens Health Act; H.R. 3851/S. 2464, Access to Breast Cancer Diagnosis Act of 2023; S. 964, Mothers and Newborns Success Act; H.R. 4572/S. 2303, Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023; H.R. 4534/S. 2245, Women and Lung Cancer Research and Preventive Services Act of 2023; S. 3447, Pregnant and Postpartum Women Treatment Reauthorization Act; S. 3370, Promoting Maternal and Child Health Through Substance Use Prevention Act; H.R. 3946/S. 1800, FASD Respect Act; H.R. __ /S.__ Strengthening Pathways to Health Professions Act; Health Insurance Portability and Accountability Act (general); Patient-physician relationship (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); Reproductive health data privacy (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Coverage for infertility (general); Protections for in vitro fertilization (general); HPV vaccination (general); RSV vaccination (general); Remote patient monitoring (general); Fertility preservation services for sickle cell patients treated with cell and gene therapies; Prenatal supplements (general); Care for pregnant and postpartum incarcerated individuals (general); Gun violence as a public health issue (general);; H.Res.1448, Expressing the sense of the House of Representatives that every person has the basic right to emergency health care, including abortion care; CURES 2.0 Act; NIH restructuring (general); family care plans (general); FDA Advisory Committees (general); FDA Diversity Action Plan (general); NICHD Strategic Plan (general); physician liability (general); pharmacist-prescribed contraceptives (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) food packages (general); Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability rule (general).

Client expense: $155,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office

S. 3565, Affordable Connectivity Program Extension Act of 2024, all provisions; Draft Bill, Sustain 340B Program Discussion Draft, Issues pertaining to 340B Program access; S. 1302/H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions; S. 3679/H.R. 7153, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; S.2415, Preventing Maternal Deaths Reauthorization Act, all provisions; H.R. 7931, Preserving Emergency Access in Key Sites Act (PEAKS) , all provisions; H.R. 8245, Rural Hospital Stabilization Act , all provisions; H.R. 8246, Second Chances for Rural Hospitals Act, all provisions; S.940/ H.R. 1711, Rural America Health Corps Act, all provisions; S.665 / H.R. 4942, Conrad State 30 and Physician Access Reauthorization Act, all provisions; S. 3211/ H.R. 6205, Healthcare Workforce Resilience Act, all provisions; S. 3765 / H.R. 6960, Emergency Medical Services for Children Reauthorization Act of 2024, all provisions; H.R. 7635, The 340B PATIENTS Act, all provisions; H.R.8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net (340B ACCESS) Act, Issues pertaining to 340B Program access; S. 2364, Mapping Americas Pharmaceutical Supply Act, all provisions; S. 1961, Pharmaceutical Supply Chain Risk Assessment Act of 2023, all provisions; S. 2510, RAPID Reserve Act, all provisions; S. 2362, Drug Shortage Prevention Act, all provisions; Draft Bill, the Drug Shortage Prevention and Mitigation Act, Issues pertaining to proposed solutions to address generic drug shortages; S. 862, Restoring America's Health Care Workforce and Readiness Act, all provisions; HR 2584/ S.2768, Safety From Violence for Healthcare Employees (SAVE) Act, all provisions; S.4079/H.R. 8383, Rural Obstetrics Readiness Act , all provisions; H.R. 8186, Healthy Affordable Housing Act, all provisions; S. 4289, Medical Debt Cancellation Act, all provisions; S. 4054, Health Care Cybersecurity Improvement Act of 2024, all provisions; S. 3770/ H.R. 7266, "The Future Advancement of Academic Nursing (FAAN Act)", all provisions; S. 1176 / H.R. 2663, Workplace Violence Prevention for Health Care and Social Service Workers Act, all provisions; H.R. 977/S. 470, Patient Access to Higher Quality Care Act, all provisions; Draft Bill, Family Health Affordability Act, all provisions; Draft Bill, HEALTH for MOM Act, all provisions; U.S. Department of Labor, Health Plan Accountability, health plan accountability; Office of the U.S. Trade Representative, Section 301 Tariffs, Issues related to tariffs on health care products manufactured in China; Federal Emergency Management Agency (FEMA), Public Assistance for COVID expenses, Issues related to distribution of public assistance funds to hospitals; Administration for Strategic Preparation & Response (ASPR / HHS), Pediatric Emergencies, Issues related to Pediatric Disaster Care Centers of Excellence; U.S. Department of State Immigration, Issues related to visas for foreign-trained health care workers; Immediate Office of the Secretary (IOS - HHS), Medical Debt, Issues related to how hospitals address medical debt; Cyber Security, Issues pertaining to Change Health Care cyber attack, breach notifications and ongoing cyber risks to the health care field; Lab Developed Tests (LDTs), Issues related to proposed regulatory oversight of Lab Developed Tests (LDTs); Employment Retirement Income Security Act (ERISA), ERISA improvements; Artificial Intelligence (AI), AI use in health care; Rural Health Care Access, Issues to protect access to rural health care; Prescription drug shortages, Issues pertaining to Drug shortages, supply chains; Hospital mergers and acquisitions, Issues pertaining to hospital consolidation, mergers an acquisition, community benefit, physician practice acquisition; Workforce nurse staffing mandate, workforce development programs; Maternal Health and Child Health, Access to maternal and child health care and addressing related workforce shortages; Behavioral Health, Related to expanding access to care and reducing regulatory barriers; Price Transparency, Issues related to hospital price transparency; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay and cost-based reimbursement for critical access hospitals under Medicare Advantage; Medical Debt, Issues specific to medical debt incurred by patients and hospital billing and collection practices; Physician Owned Hospitals, Physician-owned hospitals; Tax-exempt status, not-for-profit hospitals' tax exempt status; Health Professions Diversity, Increasing health professionals of color, National health service corps; centers of excellence; health careers opportunity programs.

Client expense: $6,080,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)